share_log

Empower Clinics Names New General Manager of Medisure Laboratory

Empower Clinics Names New General Manager of Medisure Laboratory

Empower Clinics任命新的醫療實驗室總經理
Accesswire ·  2022/11/24 16:30

Eric Christian brings twenty years of experience in healthcare industry including scaling diagnostics laboratory

埃裏克·克里斯蒂安在醫療行業擁有20年的經驗,包括擴展診斷實驗室

VANCOUVER, BC / ACCESSWIRE / November 24, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory - announces that Eric Christian is the new General Manager at Medisure Labs.

温哥華,BC/ACCESSWIRE/2022年11月24日/Empower Clinics Inc.(CSE:EPW)(OTCQB:EPWCF)("增強能力“或”公司一家通過醫療中心、醫療設備公司和高複雜性醫療診斷實驗室為患者提供服務的綜合醫療保健公司宣佈,埃裏克·克里斯蒂安成為Medisure實驗室的新任總經理。

Eric has twenty years of experience as a proven leader and entrepreneur - with both business development and operational expertise - in the medical industry. He has an established network of physicians throughout the Dallas/Fort Worth region. In his model of creating long term partnerships with physicians to service their needs, Eric has provided medical solutions including spine implants, allograft, biologics, and intraoperative neurophysiological monitoring.

Eric擁有20年的醫療行業領導者和企業家經驗,擁有業務開發和運營方面的專業知識。他在達拉斯/沃斯堡地區擁有成熟的醫生網絡。在與醫生建立長期合作伙伴關係以滿足他們需求的模式中,Eric提供了包括脊柱植入、同種異體移植、生物製劑和術中神經生理監測在內的醫療解決方案。

Specifically in the diagnostic laboratory space, Eric was part the founding management team of a successful lab in Dallas - that counted 150 employees and processed 15,000 specimens per month- and played a key business and operational role to achieve rapid growth. He established and streamlined workflows and processes to build a solid foundation for growth. He engaged physicians throughout the Dallas region and co-developed new products and services that had immediate take up. Eric also played a key role in strategic acquisitions including the purchase of an ambulatory surgery centre. He has both MBA (2001) and BA (1999) in Political Science from Texas Tech University.

具體地説,在診斷實驗室領域,Eric是達拉斯一個成功實驗室的創始管理團隊的一部分,該實驗室擁有150名員工,每月處理15,000個樣本,並在實現快速增長方面發揮了關鍵的業務和運營作用。他建立並簡化了工作流程和流程,為增長奠定了堅實的基礎。他聘請了達拉斯地區的醫生,並共同開發了新的產品和服務,這些產品和服務立即投入使用。埃裏克還在戰略收購中發揮了關鍵作用,包括收購了一家門診手術中心。他擁有得克薩斯理工大學政治學碩士學位(2001)和學士學位(1999)。

"I am very pleased that a leader of the caliber of Eric is joining our team to lead Medisure Labs," stated Steven McAuley, Chairman and CEO of Empower Clinics. "We stand to benefit immensely from his proven track record of scaling a diagnostics laboratory. With Eric at the helm, our entire team including shareholders can find renewed confidence in realizing the potential of our laboratory business and fulfilling synergies between MediSure's innovative at-home testing solutions, product development and its imminent US market entry. "

Empower診所董事長兼首席執行官Steven McAuley表示:“我非常高興像Eric這樣的領導者加入我們的團隊,領導Medisure實驗室。”我們將從他擴大診斷實驗室的成熟記錄中受益匪淺。在埃裏克的領導下,我們包括股東在內的整個團隊可以重新充滿信心,實現我們實驗室業務的潛力,並實現MediSure創新的家庭測試解決方案、產品開發和即將進入美國市場之間的協同效應。

"There is an impressive foundation to build on at Medisure Labs," said Eric Christian, new General Manager of Medisure Labs. "I've visited and led many labs over the last two decades. I can confirm that Medisure Labs is one of the cleanest and well-designed state-of-the-art facilities that I have ever seen. It sits at a prime location in the heart of the Dallas medical district. Coupled with MediSure's at-home testing solutions, I'm incredibly excited to roll out unique health solutions for the US market that leverage both our in-house diagnostics and medical device capabilities. For these reasons I have accepted the challenge to lead the lab, immediately commence sales efforts to deliver on its revenue potential and join a team that can offer convenient integrated healthcare solutions to the U.S."

醫療保險實驗室的新任總經理埃裏克·克里斯蒂安説:“醫療保險實驗室有着令人印象深刻的基礎。”在過去的二十年裏,我參觀並領導了許多實驗室。我可以肯定,Medisure實驗室是我見過的最乾淨、設計最先進的設施之一。它位於達拉斯醫療區中心的黃金地段。再加上MediSure的家庭測試解決方案,我非常高興能為美國市場推出獨特的健康解決方案,利用我們的內部診斷和醫療設備能力。出於這些原因,我接受了領導該實驗室的挑戰,立即開始銷售工作,以實現其收入潛力,並加入一個能夠向美國提供方便的集成醫療解決方案的團隊。“

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management

本新聞稿可在AGORACOM上的授權診所驗證論壇上獲得,以供股東討論、提問和與管理層接觸

ABOUT EMPOWER:

關於授權:

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

Empower是一家綜合性醫療保健公司,通過其診所、數字和遠程醫療護理、醫療設備公司和世界級醫療診斷實驗室為患者提供身心健康。在經驗豐富的領導團隊的支持下,Empower正在北美地區積極擴大其臨牀和數字業務。我們的健康與健康和診斷與技術業務部門將積極影響我們患者的整體健康,同時為我們的股東提供長期價值。

ON BEHALF OF THE BOARD OF DIRECTORS:

我謹代表董事會:

Steven McAuley
Chief Executive Officer

史蒂文·麥考利
首席執行官

CONTACTS:

聯繫人:

Media:
Steven McAuley CEO
s.mcauley@empowerclinics.com
+1 855-855-9058

媒體:
史蒂文·麥考利首席執行官
郵箱:s.mcauley@empower Clinics.com
+1 855-855-9058

Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
+1 855-855-9058

投資者:
塔瑪拉·梅森
業務發展與溝通
郵箱:t.mason@empower Clinics.com
+1 855-855-9058

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

對前瞻性陳述的免責聲明

This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding: the likelihood or ability for the Company to secure new testing business, that realizing the potential of the laboratory business and fulfilling synergies between MediSure's innovative at-home testing solutions, product development and its imminent US market entry will happen or be attained. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company may be unable to enter into definitive agreements, or close transactions with respect to, proposed future clinic openings; that due diligence with respect to anticipated clinic openings and acquisitions may not be satisfactory to the Company; risks related to delays in permitting or construction; risks related to supply chains and access to labour; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for new clinics; general business, economic, competitive, political and social uncertainties; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

本新聞稿包含適用於加拿大證券法的某些“前瞻性陳述”或“前瞻性信息”(統稱為“前瞻性陳述”)。除有關歷史事實的陳述外,所有陳述均為前瞻性陳述,均基於截至本新聞稿發佈之日的預期、估計和預測。前瞻性表述常常可以用“計劃”、“繼續”、“預期”、“項目”、“打算”、“相信”、“預期”、“估計”、“可能”、“將”、“潛在”、“建議”和其他類似詞語,或某些事件或條件“可能”或“將”發生的信息來識別。本新聞稿中的前瞻性陳述包括:公司獲得新測試業務的可能性或能力,實現實驗室業務的潛力,實現MediSure創新的家庭測試解決方案、產品開發和即將進入美國市場之間的協同效應。此類前瞻性表述基於管理層目前已知的假設,可能會受到風險和不確定性的影響,這些風險和不確定性可能會導致實際結果、業績或發展與前瞻性表述中包含的內容大不相同,包括:公司可能無法就以下方面達成最終協議或完成交易, 前瞻性表述包括:預期的未來診所開業計劃;預期診所開業和收購的盡職調查可能令公司不滿意;與批准或建設延遲相關的風險;與供應鏈和勞動力獲取有關的風險;法規變化可能對公司的業務和產品開發產生不利影響;公司可能無法獲得足夠的資金來實施其業務計劃;公司將能夠開始和/或完成新診所的擴建和租户改造;一般業務、經濟、競爭、政治和社會不確定性;以及公司無法控制的其他因素。不能保證前瞻性陳述中預期的任何事件將按照預期的條款或時間發生,或者根本不能保證,或者如果發生了,公司將從中獲得什麼好處。告誡讀者不要過度依賴本新聞稿中的前瞻性陳述,這些前瞻性陳述完全受這些警告性陳述的限制。除適用的證券法明確要求外,公司沒有義務更新或修改本新聞稿中的任何前瞻性陳述,除非適用的證券法明確要求,無論是由於新信息、未來事件還是其他原因。

SOURCE: Empower Clinics Inc.

資料來源:Empower Clinics Inc.


View source version on accesswire.com:
在accesswire.com上查看源代碼版本:

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論